Marco Zarbin

Guillaume Stern (Partner, Reinhold Cohn Group; rcip.co.il; @ReinholdCohnIP) will provide annual summaries of patent applications involving translational vision science. Look for the 1st in Jan 2023 @ARVOtvst (#openaccess, #VisionScience, #DataScience, #DataSharing).

Chen et al published an open-source annotated glaucoma medication dataset derived from clinical notes in the EHR in @ARVOtvst, an #openaccess journal for the #visionscience community. So, annotated free-text clinical notes can be de-identified for upload as an open data set.

#Mendelianrandomization (MR) combines genetic data with epidemiology & can limit #confounding. Liu et al (doi:doi.org/10.1167/tvst.1…) use MR to assess whether antiHTN drugs can be repurposed to treat #glaucoma. @ARVOtvst is #openaccess for the #visionscience community.

In the latest issue of @ARVOTVST, Drs. Cabrera and Chen explain why we need to reform our perspectives on @race and @glaucoma. TVST is an @openaccess journal, so everyone can read this provocative editorial (bit.ly/3Su1LnE).

Ryan et al generated a transcriptome of human retinal endothelial cells in the unstimulated state and following treatment with inflammatory cytokines linked to cell dysfunction. These important data are published in the Data Science Section of TVST (bit.ly/3dNNseC).

In TVST, Kang et al (doi.org/10.1167/tvst.1…), show that in POAG, risks of VF loss regional patterns derived from machine learning algorithms exhibit racial differences: Blacks, compared to non-Hispanic whites, have higher risks of POAG with early central and advanced VF loss.

Please check out the latest #DataScience paper in @ARVOtvst: Simple Code Implementation for Deep Learning-Based Segmentation to Evaluate Central Serous Chorioretinopathy in Fundus Photography! It's #openaccess for the #visionscience community!

Sonogenetics may be a novel method for vision restoration. To learn more, see the #RegenerativeMedicine issue in @ARVOtvst. It's #openaccess and focused on #translational #VisionScience.

@ARVOtvst features its first #DataScience paper today by Aaron Lee and colleagues! Please check it out at: tvst.arvojournals.org/article.aspx?a…. TVST is an #OpenAccess journal, highlighting developments in #OcularTherapy and #VisionScience

Call for papers! @ARVOtvst Special Issue: Sustained Delivery Technologies for Ocular #Therapeutics. Submission deadline: March 1, 2022 Learn more: tvst.arvojournals.org TVST is an #OpenAccess journal, highlighting developments in #OcularTherapy and #VisionScience

Flash! For those interested in #visionscience worldwide. Special issue: #Regenerativemedicine in @ARVOTVST is #openaccess, highlighting developments in #celltherapy, #genetherapy,& #prosthetics for cornea, lens, & retina: tvst.arvojournals.org/issues.aspx

Check out the new publications in @ARVOTVST, which is an #openaccess journal featuring the latest translational research in #visionscience worldwide: tvst.arvojournals.org/issues.aspx

3-in-1 DL module assesses image quality, field of view, and eye laterality in retinal photographs. New and free to read in TVST: doi.org/10.1167/tvst.1… @CUHKofficial @QUBMedEd CPH_QUB @NTUsg @snec_seri @NUSMedicine #AI #Retina #ophthalmology #OpenAccess

Check out the new publications in @ARVOTVST, which is an #openaccess journal featuring the latest translational research in #visionscience worldwide: tvst.arvojournals.org/issues.aspx

Ophthopedia Update: Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy dlvr.it/S0SwC7 #Ophthalmology #Ophthotwitter #BJO

Check out one of our most-read articles in the last month: "Written in Blood: Applying Shape Grammars to Retinal Vasculatures.” Full article is free w/o a subscription: doi.org/10.1167/tvst.9… @CMU_Mech @UPMCnews #Retina #ImageProcessing #Biomarkers #OpenAccess #Ophthalmology

The @ARVOTVST special issue on corneal #crosslinking is now online (#openaccess)! #issueid=938528" target="_blank" rel="nofollow noopener">tvst.arvojournals.org/issues.aspx?is…

@Gabyk87174018 Test

@Gabyk87174018 Thank you, Gabriella!